Ragosa Mark bought KNSA
October 28, 2025 · Form 4 insider transaction
Ragosa Mark bought 100 shares of Kiniksa Pharmaceuticals International, plc at $30.93 per share, a transaction worth $3.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
100
Price
$30.93
Total value
$3.1K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateOctober 28, 2025
Filing dateOctober 30, 2025
Shares owned after31,186
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 3, 2024.